Related Experiment Video
Updated: May 3, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Pathological Mechanism and Treatment of Calcified Aortic Stenosis
Si-Yu Chen1, Xiang-Quan Kong1,2, Jun-Jie Zhang1,2
1Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China, Nanjing 210006, China.
Insights
Calcified aortic stenosis (AS) is a common heart valve disease causing blood flow obstruction. Current treatments focus on valve replacement, as no drugs effectively slow AS progression.
Area of Science:
- Cardiology
- Pathobiology
- Medical Research
Background:
- Calcified aortic stenosis (AS) is a prevalent valvular heart disease globally.
- It involves complex pathobiology including inflammation, cell changes, and lipid deposition.
- Currently, aortic valve replacement is the primary treatment for AS.
Purpose of the Study:
- To review the etiology, diagnosis, and management of calcified aortic stenosis.
- To explore the intricate pathobiology of AS.
- To propose novel therapeutic targets for AS.
Main Methods:
- Literature review of etiology, diagnosis, and management.
- Analysis of pathobiological mechanisms.
- Identification and discussion of potential therapeutic targets.
Main Results:
- AS is characterized by progressive fibrocalcific remodeling leading to blood flow obstruction.
- Pathobiology involves endothelial dysfunction, inflammation, and cellular changes.
- No current drug therapy effectively slows AS progression.
Conclusions:
- Aortic valve replacement remains the optimal treatment for AS.
- Understanding AS pathobiology is crucial for developing new therapies.
- Novel therapeutic targets for AS warrant further investigation.
Abstract:
Calcified aortic stenosis (AS) is one of the most common valvular heart diseases worldwide, characterized by progressive fibrocalcific remodeling and thickening of the leaflets, which ultimately leads to obstruction of blood flow. Its pathobiology is an active and complicated process, involving endothelial cell dysfunction, lipoprotein deposition and oxidation, chronic inflammation, phenotypic transformation of valve interstitial cells, neovascularization, and intravalvular hemorrhage. To date, no targeted drug has been proven to slow down or prevent disease progression. Aortic valve replacement is still the optimal treatment of AS. This article reviews the etiology, diagnosis, and management of calcified aortic stenosis and proposes novel potential therapeutic targets.
More Related Videos
04:30Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
05:47Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro
Published on: May 10, 2021
Related Concept Videos
Antihypertensive Drugs: Vasodilators
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Aortic Regurgitation III: Medical Management
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis III: Management
Peripheral Artery Disease III: Interprofessional Care